Sutro Biopharma Inc (STRO)
2.51
-0.02
(-0.79%)
USD |
NASDAQ |
Nov 22, 16:00
2.52
+0.01
(+0.40%)
After-Hours: 20:00
Sutro Biopharma Profit Margin (Quarterly): -572.6% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -572.6% |
| June 30, 2024 | -186.8% |
| March 31, 2024 | -447.5% |
| December 31, 2023 | 27.32% |
| September 30, 2023 | -291.2% |
| June 30, 2023 | -370.0% |
| March 31, 2023 | -394.9% |
| December 31, 2022 | -400.8% |
| September 30, 2022 | -77.50% |
| June 30, 2022 | -92.58% |
| March 31, 2022 | -663.2% |
| December 31, 2021 | -357.8% |
| September 30, 2021 | -362.8% |
| June 30, 2021 | -21.93% |
| March 31, 2021 | -207.1% |
| Date | Value |
|---|---|
| December 31, 2020 | -719.3% |
| September 30, 2020 | 96.16% |
| June 30, 2020 | |
| March 31, 2020 | -274.0% |
| December 31, 2019 | -130.8% |
| September 30, 2019 | -105.2% |
| June 30, 2019 | -131.0% |
| March 31, 2019 | -165.1% |
| December 31, 2018 | -7.82% |
| September 30, 2018 | -130.6% |
| June 30, 2018 | -202.3% |
| March 31, 2018 | -207.9% |
| December 31, 2017 | -379.8% |
| September 30, 2017 | -8.10% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-719.3%
Minimum
Dec 2020
96.16%
Maximum
Sep 2020
-286.7%
Average
-291.2%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -99.41% |
| Return on Assets | -27.58% |
| Return on Invested Capital | -97.66% |
| Operating Margin (Quarterly) | -797.2% |
| Return on Net Operating Assets | -200.8% |